Market Overview:
The global blood plasma market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of chronic diseases, rising demand for plasma-derived products, and technological advancements in the field of blood plasma fractionation. Based on type, the global blood plasma market is segmented into immunoglobulin, albumin, protease inhibitors, coagulation factor concentrates, and others. Immunoglobulin accounted for the largest share of the global blood plasma market in 2017 and is projected to grow at a CAGR of 6% from 2018 to 2030. Albumin held second largest share in 2017 and is projected to grow at a CAGR of 5% during forecast period. Protease inhibitors are expected witness highest growth rate during forecast period owing rising prevalence chronic diseases such as cancer and HIV/AIDS across globe . Coagulation factor concentrates are also anticipated witness high growth rate due their usage as therapeutics agent for various indications such as hemophilia & Von Willebrand disease (VWD). Based on application , hospitals & clinics accounted for majority share followed by research laboratories & academic institutions respectively .
Product Definition:
blood plasma is the clear, straw-colored liquid portion of blood that contains clotting factors, proteins, electrolytes, and other substances needed for the proper functioning of the body. It forms approximately 55% of total blood volume and is used in transfusions to replace lost blood or plasma.
Immunoglobulin:
Immunoglobulin is the term used for antibodies in the blood. It's a protective mechanism by which the body reacts to harmful bacteria and viruses. The immunoglobulin present in blood plasma acts as a shield that protects against bacterial and viral infections.
Albumin:
Albumin is the most abundant protein in the human blood plasma. It accounts for approximately 45% of total proteins and is responsible for maintaining normal blood volume and pressure. Albumin has a high content of amino acids, making it an ideal source to provide essential nutrients to cells that cannot be synthesized through diet alone.
Application Insights:
The hospitals and clinics segment dominated the global blood plasma market in 2017, accounting for a revenue share of more than 60%. The segment is expected to witness significant growth owing to rising demand for therapeutic products. Increasing prevalence of chronic diseases such as diabetes, anemia and autoimmune disorders has led to increased usage of blood plasma-based therapies.
Blood Plasma Protein Therapeutics (BPTP) Market by Type (Immunoglobulin, Albumin), By Application (Hospitals & Clinics, Research Laboratories), And Region - North America; Europe; Asia Pacific; Latin America; MEA BPTP Hospitals & Clinics held the largest share in 2017 due largely to factors such as high usage rates of immunoglobulins and albumin therapy in patients with hemophilia and immune deficiency diseases.
Regional Analysis:
North America dominated the global blood plasma market in 2017. The presence of well-established healthcare infrastructure, high patient awareness levels coupled with relatively higher healthcare expenditure in this region are some factors responsible for its large share.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing demand for immunoglobulin and albumin products from emerging countries such as China and India. In addition, rising prevalence of chronic diseases such as cancer and diabetes will drive the regional market further on account of growing need for therapeutics that require parenteral administration.
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is expected to drive the demand for blood plasma products as they are used in the treatment of a wide range of chronic diseases.
- Technological advancements: The development and commercialization of novel technologies for the production and purification of blood plasma products is expected to spur growth in the market over the next few years.
- Rising awareness about blood donation: There has been a rise in awareness about blood donation across the globe in recent years, which is likely to boost demand for blood plasma products in coming years.
- Growing population: The world’s population is growing at a rapid pace, which will result in an increase in demand for various medical treatments including those that useblood plasma products. 5) Rise In Number Of Trauma Cases And Road Accidents :The number if trauma cases and road accidents are on rise globally ,thus leading too increased requirement off Blood Plasma
Scope Of The Report
Report Attributes
Report Details
Report Title
Blood Plasma Market Research Report
By Type
Immunoglobulin, Albumin, Protease Inhibitors, Coagulation Factor Concentrates, Others
By Application
Hospitals and Clinics, Research Laboratories, Academic Institutions
By Companies
Baxter International, CSL, Grifols, Octapharma, ADMA Biologics, Cerus Corp, Sanquin, Shanghai Raas, TCS Biosciences, Baxter International
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Blood Plasma Market Report Segments:
The global Blood Plasma market is segmented on the basis of:
Types
Immunoglobulin, Albumin, Protease Inhibitors, Coagulation Factor Concentrates, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Research Laboratories, Academic Institutions
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Baxter International
- CSL
- Grifols
- Octapharma
- ADMA Biologics
- Cerus Corp
- Sanquin
- Shanghai Raas
- TCS Biosciences
- Baxter International
Highlights of The Blood Plasma Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immunoglobulin
- Albumin
- Protease Inhibitors
- Coagulation Factor Concentrates
- Others
- By Application:
- Hospitals and Clinics
- Research Laboratories
- Academic Institutions
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Blood Plasma Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Blood plasma is the liquid component of blood. It contains red and white blood cells, platelets, and other proteins. Plasma helps to carry oxygen to the body's tissues and removes waste products from the cells.
Some of the major players in the blood plasma market are Baxter International, CSL, Grifols, Octapharma, ADMA Biologics, Cerus Corp, Sanquin, Shanghai Raas, TCS Biosciences, Baxter International.
The blood plasma market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Blood Plasma Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Blood Plasma Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Blood Plasma Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Blood Plasma Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Blood Plasma Market Size & Forecast, 2018-2028
4.5.1 Blood Plasma Market Size and Y-o-Y Growth
4.5.2 Blood Plasma Market Absolute $ Opportunity
Chapter 5 Global Blood Plasma Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Blood Plasma Market Size Forecast by Type
5.2.1 Immunoglobulin
5.2.2 Albumin
5.2.3 Protease Inhibitors
5.2.4 Coagulation Factor Concentrates
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Blood Plasma Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Blood Plasma Market Size Forecast by Applications
6.2.1 Hospitals and Clinics
6.2.2 Research Laboratories
6.2.3 Academic Institutions
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Blood Plasma Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Blood Plasma Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Blood Plasma Analysis and Forecast
9.1 Introduction
9.2 North America Blood Plasma Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Blood Plasma Market Size Forecast by Type
9.6.1 Immunoglobulin
9.6.2 Albumin
9.6.3 Protease Inhibitors
9.6.4 Coagulation Factor Concentrates
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Blood Plasma Market Size Forecast by Applications
9.10.1 Hospitals and Clinics
9.10.2 Research Laboratories
9.10.3 Academic Institutions
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Blood Plasma Analysis and Forecast
10.1 Introduction
10.2 Europe Blood Plasma Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Blood Plasma Market Size Forecast by Type
10.6.1 Immunoglobulin
10.6.2 Albumin
10.6.3 Protease Inhibitors
10.6.4 Coagulation Factor Concentrates
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Blood Plasma Market Size Forecast by Applications
10.10.1 Hospitals and Clinics
10.10.2 Research Laboratories
10.10.3 Academic Institutions
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Blood Plasma Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Blood Plasma Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Blood Plasma Market Size Forecast by Type
11.6.1 Immunoglobulin
11.6.2 Albumin
11.6.3 Protease Inhibitors
11.6.4 Coagulation Factor Concentrates
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Blood Plasma Market Size Forecast by Applications
11.10.1 Hospitals and Clinics
11.10.2 Research Laboratories
11.10.3 Academic Institutions
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Blood Plasma Analysis and Forecast
12.1 Introduction
12.2 Latin America Blood Plasma Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Blood Plasma Market Size Forecast by Type
12.6.1 Immunoglobulin
12.6.2 Albumin
12.6.3 Protease Inhibitors
12.6.4 Coagulation Factor Concentrates
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Blood Plasma Market Size Forecast by Applications
12.10.1 Hospitals and Clinics
12.10.2 Research Laboratories
12.10.3 Academic Institutions
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Blood Plasma Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Blood Plasma Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Blood Plasma Market Size Forecast by Type
13.6.1 Immunoglobulin
13.6.2 Albumin
13.6.3 Protease Inhibitors
13.6.4 Coagulation Factor Concentrates
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Blood Plasma Market Size Forecast by Applications
13.10.1 Hospitals and Clinics
13.10.2 Research Laboratories
13.10.3 Academic Institutions
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Blood Plasma Market: Competitive Dashboard
14.2 Global Blood Plasma Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Baxter International
14.3.2 CSL
14.3.3 Grifols
14.3.4 Octapharma
14.3.5 ADMA Biologics
14.3.6 Cerus Corp
14.3.7 Sanquin
14.3.8 Shanghai Raas
14.3.9 TCS Biosciences
14.3.10 Baxter International
